iCRT-14
CAS: 677331-12-3
Ref. 3D-FI24534
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Informação sobre produto
- 5-[[2,5-Dimethyl-1-(3-pyridinyl)-1H-pyrrol-3-yl]methylene]-3-phenyl-2,4-thiazolidinedioneiCRT 14iCRT14
iCRT-14 is a drug that has been shown to be effective in the treatment of a number of different diseases. It is a pluripotent cell therapy that is derived from skin cells which are grown and then induced to differentiate into other types of cells, such as cardiac cells. iCRT-14 has been shown to be capable of reversing the progression of some types of breast cancer by activating transcription-polymerase chain reaction (PCR) and increasing epidermal growth factor levels. The activation of cell signaling pathways, such as c-jun phosphorylation, also plays a role in iCRT-14's effect on cancer cells.
Propriedades químicas
Consulta técnica sobre: 3D-FI24534 iCRT-14
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
